Violation Tracker Individual Record
: Genentech Inc.
Current Parent Company
Parent at the Time of the Penalty AnnouncementPenalty
to see this data field
: June 6, 2016
: government-contracting-related offenses
: False Claims Act and related
: Pharmaceutical companies Genentech Inc. and OSI Pharmaceuticals LLC agreed to pay $67 million to resolve False Claims Act allegations that they made misleading statements about the effectiveness of the drug Tarceva to treat non-small cell lung cancer. The announcement did not indicate how much each company would pay. Here we assume the total was split evenly between them.
Level of Government
: agency action
: Justice Department Civil Division
Civil or Criminal Case
HQ Country of Current Parent
Ownership Structure of Current Parent
: publicly traded
Major Industry of Current Parent
Specific Industry of Current Parent
Source of Data
: (click here)
: If an online information source is not working, check the Violation Tracker Data Sources page
for an updated link.
Current parent company note
: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log